Skip to content

Effectiveness of multidisciplinary medical team education for heart failure patients to improve their medication adherence

Effectiveness of multidisciplinary medical team education for heart failure patients to improve their medication adherence - Effectiveness of multidisciplinary medical team education for heart failure patients to improve their medication adherence

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000031192
Enrollment
40
Registered
2018-02-07
Start date
2018-02-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

None listed

Sponsors

Kameda General Hospital
Lead Sponsor
Tokyo University of Pharmacy and Life Sciences The University of Tokyo, The Institute of Medical Science
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patient with consent ability. 2) Patients who are admitted to hospital resulted from acute heart failure. 3) Patients who are regularly used at least 1 medication for heart failure and co-morbidities causing the heart failure.

Exclusion criteria

Exclusion criteria: 1) Death and changing departments during hospitalization. 2) Patient discharged to the medical facilities or other hospitals. 3) Patients after leaving hospital who visit other hospitals and clinics. 4) Dementia : Mini-Mental State Examination (MMSE) score <= 23. 5) Patient who are used no medication before admission.

Design outcomes

Primary

MeasureTime frame
Level of adherence classification (High, Medium, Low) evaluated by the Morisky Medication Adherence Scale 8-items (MMAS-8)

Secondary

MeasureTime frame
1) Transition of MMAS-8 score of visit 1 and visit 2 2) Transition of Visual Analogue rating Scale (VAS) of patients admission, visit 1 and visit 2

Countries

Japan

Contacts

Public ContactTomoaki Hashimoto

Kameda General Hospital Department of pharmacy

hashimoto.tomoaki@kameda.jp04-7092-2211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026